Arrowmsith Genetic Inc. is a preclinical-stage drug discovery company in Vancouver, BC, Canada.

The company was spun out of UBC and BC Cancer in May 2024 to mobilize inventions based on 20+ years of genetic research and insights in the labs of Phil Hieter and Peter Stirling.

Interested in Learning more? Email info@arrowsmithgenetics.com